Common Fact Discovery in Philips CPAP/BiPAP Lawsuits Moving Forward in MDL

Exchange of information will help the parties determine which Philips CPAP/BiPAP lawsuits will be selected for early trial dates in the litigation

While a growing number of Philips CPAP/BiPAP lawsuits continue to be filed by former users of recalled sleep apnea machines diagnosed with cancer, lung damage and other injuries, the U.S. District Judge presiding over the litigation has authorized the parties commence general fact discovery on common issues in the claims.

Philips Respironics faces thousands of product liability claims brought in the federal court system, each raising similar allegations that former users of recalled DreamStation, CPAP, BiPAP and mechanical ventilators were left with injuries caused by a toxic sound abatement foam inside the devices, which has been found to be prone to break down and degrade, releasing black particles and chemicals directly into the users’ lungs.

Philips CPAP recall was first announced in June 2021, impacting millions of devices sold between 2009 and early 2021, which contained a polyester-based polyurethane (PE-PUR) foam designed to reduce noise and vibrations while the machines were used at night for treatment of sleep apnea. However, there is now increasing evidence the manufacturers knew for years that the foam was breaking down, yet withheld information from consumers and federal regulators until a new design was introduced in April 2021.

Former users of the recalled sleep apnea machines have already reported developing various types of cancer and lymphoma, as well as permanent lung damage, kidney disease, liver disease and other side effects from the Philips CPAP foam.

Stay Up-to-Date About

Philips CPAP Recall Lawsuits sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Philips CPAP recall lawsuit updates or developments.

"*" indicates required fields

Given common questions of fact and law raised lawsuits filed throughout the federal court system, the Philips CPAP litigation has been centralized before Senior U.S. District Judge Joy Flowers Conti in the Western District of Pennsylvania for coordinated discovery and pretrial proceedings, as part of a multidistrict litigation (MDL).

In order to begin preparing Philips CPAP/BiPAP lawsuits for trial, Judge Conti issued a case management order (PDF), which allowed the parties to commence fact discovery after July 1, 2022. The order also outlined the initial discovery plan in the litigation, and called for the parties to submit proposals last week regarding protective orders, electronically stored information (ESI) orders, and the protocol for identifying search terms that will be used during the discovery phase.

While new Philips CPAP/BiPAP lawsuits continue to be filed over the coming months and years, lawyers will engage in fact discovery regarding issues that apply to all claims. To help coordinate gathering case-specific information on each claim, the Court directed the parties to submit any stipulated forms for fact sheets which must be completed by each injured party by July 8, and a proposed order to govern depositions must be submitted by August 15.

Following a lengthy discovery process, it is expected that Judge Conti will establish a bellwether trial process, where a small group of Philips CPAP/BiPAP lawsuits will go through case-specific discovery and be prepared for a series of early trial dates to help gauge how juries may respond to certain evidence and testimony that may be repeated throughout the litigation.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Johnson & Johnson Faces Medical Monitoring Lawsuit Over Future Baby Powder Cancer Risks
Johnson & Johnson Faces Medical Monitoring Lawsuit Over Future Baby Powder Cancer Risks (Posted today)

Women who used Johnson's Baby Powder around their genitals for feminine hygiene purposes now live in fear of developing ovarian cancer, according to the class action lawsuit seeking medical monitoring for future diagnoses

More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing
More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing (Posted yesterday)

A bundled complaint of about 9,600 Suboxone lawsuits were filed in federal court on Friday, ahead of the two-year anniversary of the FDA requiring tooth decay label warnings on the opioid treatment film strips, which is also a deadline for filing a civil complaint in many states.